Interim subgroup analysis for response by PD-L1 status of CLASSICAL-Lung, a phase Ib/II study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC.
Publication Title
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Document Type
Abstract
Publication Date
5-25-2020
Clinical Institute
Cancer
Specialty
Oncology
Specialty
Earle A. Chiles Research Institute
Recommended Citation
Shafique, Michael Rahman; Fisher, Terrence Lee; Evans, Elizabeth E.; Leonard, John E.; Electa Pastore, Desa Rae; Mallow, Crystal L.; Smith, Ernest; Schroder, Andreas; Chin, Kevin M.; Beck, Joseph Thaddeus; Baumgart, Megan Ann; Govindan, Ramaswamy; Gabrail, Nashat Y.; Sanborn, Rachel E; Spira, Alexander I.; Seetharamu, Nagashree; Lou, Yanyan; Mansfield, Aaron Scott; Goldman, Jonathan Wade; and Zauderer, Maurice, "Interim subgroup analysis for response by PD-L1 status of CLASSICAL-Lung, a phase Ib/II study of pepinemab (VX15/2503) in combination with avelumab in advanced NSCLC." (2020). Articles, Abstracts, and Reports. 3775.
https://digitalcommons.providence.org/publications/3775
